Objectives: To evaluate the effectiveness of mindfulness as a complementary therapy in patients with rheumatoid arthritis. Method: Protocol numbered CRD42017080108 on the PROSPERO platform. Manual searches and the Cochrane Collation assessment instrument were performed for systematic reviews in the databases CENTRAL, MEDLINE, PEDro, PsycoINFO, LILACS, Web of Science, clinical trials.gov, WHO-ICTRP and Open Gray. Randomized controlled trials were included without language restrictions or mindfulness temporality compared to placebo, psychotherapy or another equivalent strategy in patients with rheumatoid arthritis. Results: Four primary studies included (249 participants), which compared mindfulness with waiting lists, cognitive therapy and education. They presented better scores of disease activities, depressive symptoms, psychological distress, well-being, pain catastrophization, although they were classified as having a high risk of occurrence in at least one domain of the instrument used, presenting the need for robust clinical trials, proving the effectiveness of mindfulness in clinical practice. Conclusions: Beneficial effects of mindfulness in patients with rheumatoid arthritis are shown to present important results of changes in outcomes that affect the biopsychosocial dimensions in patients with. However, the evidence from the studies evaluated is of low quality, making it difficult to recommend intervention in clinical practice.

Objetivo: Avaliar um programa de treinamento teórico/prático in loco paratécnicos e auxiliares de enfermagem sobre manobras básicas em ressuscitaçãocardiopulmonar. Método: Estudo quase-experimental desenvolvido de agostoa outubro de 2015. Participaram 96 técnicos e auxiliares de enfermagem deum hospital público do interior de São Paulo. Foi aplicado um instrumentocom vinte questões fechadas, antes e imediatamente após a capacitação. Osresultados foram analisados pelo teste de Wilcoxon pareado. Resultados:Os técnicos e auxiliares apresentaram melhor desempenho no pós-teste,respectivamente, 161% e 180 %. O maior desempenho foi no reconhecimentoda parada cardiorrespiratória (PCR), 83,3 % para auxiliares e 83, 6 % paratécnicos. Uma das principais limitações do estudo foi não se ter realizadonenhuma coleta de dados em relação à prática profissional antes e após otreinamento. Conclusão: A intervenção realizada mostrou-se eficaz, já quehouve aumento significativo nos acertos do pós-teste.

Objectives:To assess an in situ simulation-based cardiopulmonary resuscitation training strategy, with emphasis on debriefing and follow-up assessment of knowledge after training. Method:This was an educational intervention study to measure intraparticipant variability. The simulation-based teaching techniques consisted of nine steps.This research followed STROBE recommendations for the methodological development of observational studies, "See Supplementary File 1".Results: Significant differences (p < 0.05) were observed between the pre-test and post-theory assessments, and between the prepractical phase and 60 days post-training. However, no differences were observed (p<0.05) between the post-theory and post-practical phases, showing that after participating in the training strategy, after the pre-test assessment, the participants seemed to have carried over the knowledge displayed in the post-theory to the post-practical time, with considerable reduction in performance 60 days after the training program. Conclusion:Theoretical emphasis coupled with simulation practice displayed the best results in performance when compared to theoretical training alone, even at 60 days post-training.

Introduction: Multiple Sclerosis is a chronic inflammatory neurodegenerative disease of large magnitude in the world. Method and Goal:To analyze primary studies associating high dose of vitamin D with the prognosis of patients with multiple sclerosis.Results: 9 studies were selected, including 1022 participants. 630 of them were randomized to vitamin D3 supplementation in high dose, 171 in low-dose and 221 receiving placebo. Conclusion:There is evidence that high dose of Vitamin D3 provide immunomodulatory effects in patients with Multiple Sclerosis, showing improvement in the patients' prognosis.